b 352 20
Pill imprint b 352 20 has been identified as Leflunomide 20 mg.
Leflunomide is used in the treatment of rheumatoid arthritis; psoriatic arthritis and belongs to the drug classes antirheumatics, selective immunosuppressants. Not for use in pregnancy.
Leflunomide 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Leflunomide Images
- Imprint:
-
b 352
20 - Strength:
- 20 mg
- Color:
- Yellow
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
corn starch
crospovidone
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
polysorbate 80
povidone
dimethicone
sodium lauryl sulfate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
- Drug Class:
- Antirheumatics
Selective immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0352
More Leflunomide resources
- Leflunomide (Wolters Kluwer)
- leflunomide (Cerner Multum)
- leflunomide (Micromedex) - Includes Dosage Information
- Leflunomide (AHFS DI)
- Leflunomide (FDA)
- Leflunomide (Wolters Kluwer)


